Related references
Note: Only part of the references are listed.Method development for quantitative determination of seven statins including four active metabolites by means of high-resolution tandem mass spectrometry applicable for adherence testing and therapeutic drug monitoring
Lea Wagmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy
Mezgebu Legesse Habte et al.
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy (2020)
Simultaneous LC-MS/MS analysis of simvastatin, atorvastatin, rosuvastatin and their active metabolites for plasma samples of obese patients underwent gastric bypass surgery
Asma El-Zailik et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
Jong-Lyul Ghim et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
An LC-MS/MS spectrometry method for the simultaneous determination of Rosuvastatin and Irbesartan in rat plasma: Insight into pharmacokinetic and drug-drug interaction studies
Mohamed Saleh Elgawish et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Statin Toxicity Mechanistic Insights and Clinical Implications
Natalie C. Ward et al.
CIRCULATION RESEARCH (2019)
Quantification of amlodipine and atorvastatin in human plasma by UPLC-MS/MS method and its application to a bioequivalence study
Mamdouh R. Rezk et al.
BIOMEDICAL CHROMATOGRAPHY (2018)
Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction
Saad Ezad et al.
OXFORD MEDICAL CASE REPORTS (2018)
Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs
Donatella Zodda et al.
PHARMACY (2018)
Nonadherence to statins: individualized intervention strategies outside the pill box
Peter Lansberg et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2018)
Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians
Meor Fairuz Rizal Meor Anuar Shuhaili et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2017)
LC-MS/MS Method for Quantification of Atorvastatin, o-Hydroxyatorvastatin, p-Hydroxyatorvastatin, and Atorvastatin Lactone in Rat Plasma
M. Crevar-Sakac et al.
ACTA CHROMATOGRAPHICA (2016)
Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement
Maciej Banach et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Lipid-lowering efficacy of atorvastatin
Stephen P. Adams et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
LC-MS-MS Simultaneous Determination of Atorvastatin and Ezetimibe in Human Plasma
Ramzia I. El-Bagary et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Discontinuation of Statins in Routine Care Settings A Cohort Study
Huabing Zhang et al.
ANNALS OF INTERNAL MEDICINE (2013)
Development and Validation of a Highly Sensitive and Robust LC-MS/MS with Electrospray Ionization Method for Quantification of Rosuvastatin in Small Volume Human Plasma Samples and its Application to a Clinical Study
Raja Kallem et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2012)
Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor
E. Hoffart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease
Ahai Luvai et al.
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2012)
Safety of statins: an update
Miao Hu et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2012)
Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Joyce S. Macwan et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Simultaneous estimation of atorvastatin and its two metabolites from human plasma by ESI-LC-MS/MS
Chinmoy Ghosh et al.
DRUG TESTING AND ANALYSIS (2011)
Patient, Physician, and Payment Predictors of Statin Adherence
David C. Chan et al.
MEDICAL CARE (2010)
Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses
Erin Chambers et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study
Fernie J. A. Penning-van Beest et al.
EUROPEAN HEART JOURNAL (2007)
Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry
Dong-Hang Xu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS
M Hermann et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2005)
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
CA Jackevicius et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
